Bioventix

Bioventix Current Liabilities

The Current Liabilities of Bioventix (BVXP.L) as of Nov 4, 2026 is 1.40 M GBP. In the previous year, Current Liabilities was 840,317.00 GBP — a change of 67.09% (higher).

Current Liabilities

1.40 MGBP

YoY

67.09%

Last updated:

Current Liabilities of Bioventix is 2026 1.40 M GBP. Current Liabilities of Bioventix was 2025 840,317.00 GBP. It decreases by 67.09% higher compared to the previous year.

The Bioventix Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
521,130.00 GBP
Jan 1, 2020
718,306.00 GBP
Jan 1, 2021
782,622.00 GBP
Jan 1, 2022
928,867.00 GBP
Jan 1, 2023
903,155.00 GBP
Jan 1, 2024
948,545.00 GBP
Jan 1, 2025
840,317.00 GBP
Jan 1, 2026
1.40 M GBP
The Bioventix Current Liabilities history
YEARCurrent LiabilitiesYoY
1.40 MGBP+67.09%
840,317.00GBP-11.41%
948,545.00GBP+5.03%
903,155.00GBP-2.77%
928,867.00GBP+18.69%
782,622.00GBP+8.95%
718,306.00GBP+37.84%
521,130.00GBP+9.99%
473,783.00GBP+18.45%
399,986.00GBP+53.78%
260,102.00GBP+51.86%
171,282.00GBP+24.90%
137,135.00GBP-15.81%
162,897.00GBP+80.20%
90,396.00GBP-22.01%
115,907.00GBP-45.84%
214,000.00GBP-56.42%
491,000.00GBP+208.81%
159,000.00GBP+189.09%
55,000.00GBP+103.70%
27,000.00GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bioventix Stock analysis

What does Bioventix do? Bioventix PLC is a well-known British provider of high-quality antibodies and innovative diagnostic products. The company has been operating in the industry for over 20 years. They specialize in producing antibodies that are specific to certain biomarkers and proteins with high precision and reproducibility. Bioventix PLC has a unique business model that allows them to maintain a high level of control over their supply chain and build strong relationships with their customers. They not only produce antibodies themselves but also sell licenses for their patents and technologies. The company also has its own research and development department that constantly works on improving existing products and developing new diagnostic products. Their diversification into different business areas, such as food and environmental analytics, has contributed to their growth and success so far. Overall, Bioventix PLC is an innovative and growing company that offers a wide range of high-quality and innovative products. Bioventix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioventix stock

Current Liabilities of Bioventix is 1.40 M GBP in 2026.

Current Liabilities of Bioventix changed from 840,317.00 GBP to 1.40 M GBP, representing a 67.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Bioventix since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Bioventix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Bioventix

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bioventix